USPTO serial 79448276
HYDRA-MORPH SURFACE
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- HARMON, RAYMOND E
- Law office
- TMEG LAW OFFICE 103
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with HYDRA-MORPH SURFACE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and pharmaceutical preparations for use in bone repair and bone regeneration; bone void filling compositions for medical use; bioactive and osteoconductive materials for medical use; resorbable materials for filling bone defects for medical use; calcium phosphate-based preparations for medical use; freeze-dried medical preparations for reconstructive and orthopaedic purposes; medical preparations supplied in powder form for reconstitution prior to clinical application; preparations for promoting bone remodelling and bone healing; medical preparations for use in orthopaedic, trauma, dental, maxillofacial and reconstructive procedures | ACTIVE | — |
| 010 | Medical and surgical devices and implants; bone void fillers; resorbable bone substitutes; osteoconductive and bioactive bone substitute materials; medical devices for promoting bone regeneration and bone remodelling; implantable biomaterials for the treatment of bone defects; microporous and macroporous ceramic medical implants; biphasic calcium phosphate ceramic implants; implantable calcium phosphate-based bone substitutes; resorbable implantable scaffolds for bone tissue regeneration; freeze-dried medical devices for implantation; medical devices supplied in powder form for reconstitution prior to implantation; medical devices for orthopaedic, trauma, spinal, maxillofacial, dental and reconstructive surgery; surgical implants incorporating polymer binders of pharmaceutical grade; mouldable and injectable bone substitute materials for clinical use; medical devices progressively resorbed and replaced by new bone tissue during healing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 28, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 28, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 22, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 21, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 16, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |